The SAFE test consent pathway N.B. If patient declines invasive testing despite fetal anomalies and chooses to undertake the SAFE test, please document as follows prenatal diagnosis is usually advised to assess not only fetal “Invasive trisomies but also an extensive genetic array evaluation. The parents understand that the non‐invasive prenatal test (the SAFE test) is very sensitive and specific (both >99%) for fetal Trisomies, but not for other chromosomal or genetic problems.”
The SAFE test consent pathway N.B. If patient declines invasive testing despite fetal anomalies and chooses to undertake the SAFE test, please document as follows “Invasive prenatal diagnosis is usually advised to assess not only fetal trisomies but also an extensive genetic array evaluation. The parents understand that the non‐invasive prenatal test (the SAFE test) is very sensitive and specific (both >99%) for fetal Trisomies, but not for other chromosomal or genetic problems.”
SAFE_care_pathway_RSCH_v41.docx